Disease/Condition
41 Clinical Trials
6+ Countries
Type 2 Diabetes mellitus Clinical Trials Database - Free Access to 41 Studies
Access comprehensive clinical trial information for Type 2 Diabetes mellitus through Pure Global AI's free database. This collection includes 41 clinical trials across multiple phases including N/A, Not Applicable, Phase 4. Currently, 3 trials are actively recruiting participants.
Research for Type 2 Diabetes mellitus is being conducted in Japan, China, Australia and 3+ other countries. Leading sponsors include Sanofi-Aventis Recherche & Développement and Nakakinen clinic. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
27Not Applicable
6Phase 4
4Phase 3
2Phase 1/2
1By Status
Completed
27Ongoing
4Not yet recruit...
3Recruiting
3Unknown
2Top Countries
Japan9
China3
Australia2
Pakistan2
Iran1
Top Sponsors
Sanofi-Aventis Rec...3
Nakakinen clinic2
Yokohama City Univ...2
Boehringer Ingelhe...1
Diabeteszentrum Ba...1
Recent Trials
Latest clinical trials for Type 2 Diabetes mellitus
SLCTR_2018_019
Phase 4
Recruiting
Effects of delta-tocotrienol, resveratrol and vitamin D supplementation mixture on biochemical markers in diabetic patients
Higher Education Commission (H...Pakistan
ChiCTR2200056410
Phase 4
Not yet recr...
Untitled Trial
Tianjin Medical University Chu...China
IRCT20150205020965N6
Phase 2
Completed
tragacanth supplementation and type 2 diabetes
Tabriz University of Medical S...Iran
UMIN000041279
Completed
Study on the association between AGEs and sleep apnea syndrome in patients with type 2 diabetes mellitus
Yokohama City University Medic...Japan
UMIN000039484
Terminated
Study on the effect of diabetes self-management application intervention in patients with type 2 diabetes after referral to a clinic: A randomized trial between parallel groups
Yokohama City University Medic...Japan
UMIN000038801
Not Applicable
Completed
Long-term efficacy and safety of the DPP-4 inhibitors in Japanese patients with type 2 diabetes mellitus.
Nakakinen clinicJapan
IRCT20170614034526N5
Completed
Dapagliflozin Efficacy & Safety as Mono or Combination therapy in reduction of HbA1C and Body Weight in Type II Diabetes Mellitus Patients.
Hilton Pharma Pvt LtdPakistan
UMIN000037872
Not Applicable
Completed
Long-term efficacy and safety of the SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus.
Nakakinen ClinicJapan
2019-000398-21
Completed
A Phase 2a Dose-Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NLY01, a PEGylated Exenatide, when Administered as a Single Dose in Subjects with Type 2 Diabetes
Neuraly, Inc.
UMIN000037603
Not Applicable
Completed
Long-term efficacy and safety of the GLP-1 receptor agonist liraglutide in Japanese patients with type 2 diabetes mellitus.
Nakakinen clinicJapan
2017-005136-41
Ongoing
SGLT-2 Inhibition and Cardiovascular Disease. Metabolomics Study of Potential Factors Involved in Cardioprotection
Fundación Pública Andaluza par...
ChiCTR-IIR-17014234
Phase 4
Not yet recr...
Untitled Trial
The General Hospital of People...China
2017-001454-33
Ongoing
A randomized, non-blinded, 24-week pilot study to evaluate the effect of dapagliflozin (10 mg once daily) plus exenatide (2.0 mg once weekly) on type 2 diabetic patients awaiting for bariatric surgery. DEXBASU study
Dr. Albert Lecube Torello
ANZCTR12617000361303
Phase 1/2
Not yet recr...
The effect of nutraceutical supplements (Thompson’s Super Bioflavonoid Complex 'Registered Trademark') on blood glucose levels in prediabetes and type 2 diabetes- A pilot study
University of TasmaniaAustralia
2015-004224-59
Completed
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared with Metformin Up-titration Alone in Subjects with Type 2 Diabetes Mellitus
Merck Sharp & Dohme Corp.
PHRR160502-001211
Phase 3
Ongoing
Phase 3, Randomized, double-blind, placebo-controlled, 26 week multicenter study to evaluate the efficacy and safety of Ertugliflozin in Asian Subjects with Type 2 Diabetes Mellitus and inadequate glycemic control on metformin monotherapy
Merck Sharp & Dohme Corporatio...
UMIN000019192
Completed
Investigation of the Effect of Dapagliflozin on Body Composition and Diet in Japanese Patients with Type 2 Diabetes Mellitus
Department of Medicine and Bio...Japan
ChiCTR-IOR-15006941
Recruiting
Untitled Trial
The second people's hospital o...China
UMIN000018459
Not Applicable
Enrolling by...
Japan Diabetes Mellitus Effective Network System Study
National Hospital Organization...Japan
2014-004683-38
Phase 3
Completed
Effects of the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin on left ventricular myocardial DYsfunction in patients with type 2 DiAbetes mellitus and concentric left ventricular geometry.
Fondazione per il Tuo cuore on...
About Type 2 Diabetes mellitus Research
Pure Global AI provides free access to 41 clinical trials studying Type 2 Diabetes mellitus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 6+ countries.
Top research sponsors include Sanofi-Aventis Recherche & Développement, Nakakinen clinic, Yokohama City University Medical Center, among others.
Quick Facts
Total Trials41
Countries6+
Sponsors10+
Recruiting3